![Headshot of Mitzi Wasik](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Mitzi%20Wasik%20headshot.jpeg.webp?itok=BvrC9cAS)
Latest Press Releases
AMCP In the News
![Headshot of Mitzi Wasik](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Mitzi%20Wasik%20headshot.jpeg.webp?itok=BvrC9cAS)
![Health Care Innovation: AMCP’s CEO Looks at the Complex Landscape Around Prescription Drug Costs](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/healthcare-innovation-drug-prices-susan-cantrell.jpg.webp?itok=u3R171hj)
![JMCP Bloomberg Article: Drugmakers, Medicare Conclude Talks to Slash Spiraling Costs](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/bloomberg-article-drugmakers.jpg.webp?itok=dsP0_WIp)
![AMCP Foundations Best Posters 2022](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP%20Foundations%20Best%20Poster%202022.jpeg.webp?itok=2lOHn2_w)
Congratulations to Kathryn DeStefano, Matthew Dickson, and Weston Schmutz, the recipients of AMCP Foundation’s Best Poster Awards at Nexus 2022. This semiannual competition, proudly presented by AMCP Foundation with support from CVS Health, culminates twice a year at AMCP national meetings.
![BBCIC Logo](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/BBCIC-logo.jpg.webp?itok=DPJpSp8d)
Today, the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
![AMCP Health Technology Assessment Partnership Forum](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Screenshot%202024-07-16%20at%203.45.51%E2%80%AFPM.png.webp?itok=wm6vZRyZ)
Last week, nearly 50 experts in managed care convened for AMCP’s Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement.
AMCP mourns the passing of managed care pharmacy icon Judith Cahill. A former CEO of AMCP, Judy led the organization for more than 15 years, growing its membership from 600 to more than 6,000 managed care professionals.
On August 12, the House of Representatives voted to approve the Senate-passed Inflation Reduction Act, containing significant health policy reforms.
On Wednesday, June 8, the House of Representatives voted to approve the Pre-approval Information Exchange Act as part of the Food & Drug Amendments of 2022 to reauthorize the FDA User Fee Agreements.
AMCP is pleased to be recognized by the Office of Disease Prevention and Health Promotion within the U.S. Department of Health and Human Services as a Healthy People 2030 Champion.
Last week, nearly 40 experts and key stakeholders in the managed care setting convened for AMCP’s Partnership Forum: High-Investment Medications.
During AMCP Foundation's 2022 National P&T Competition, the University of Michigan received the first place prize. The competition convened student pharmacists from around the country to develop a formulary drug monograph, considering evidence gaps; value; health equity; and utilization management tools.
AMCP Foundation announces Best Poster recipients during AMCP 2022. This semiannual competition culminates twice per year at AMCP national meetings, with awards for new practitioners presented in three categories.
Mason Johnson, BS, PharmD candidate, will serve as the 2022–2023 Executive Fellow in Health Care Association Leadership. His fellowship will begin July 1, 2022.
AMCP applauds Senators Moore Capito (R-WV) and Shaheen (D-NH) and Congressmen Thompson (D-CA-5) and McKinley (R-WV-1) on the introduction of the bipartisan Access to Prescription Digital Therapeutics Act.